Women giving birth during the COVID-19 pandemic have been denied nitrous oxide (laughing gas) for pain relief due to fears of virus transmission from the aerosol-generating procedure.
Researchers at Washington University School of Medicine in St. Louis and the University of Chicago have found that a single, one-hour treatment that involves breathing in a mixture of oxygen and the anesthetic drug nitrous oxide — otherwise known as laughing gas — can significantly improve symptoms in people with treatment-resistant depression.
A new study at the University of Chicago Medicine and Washington University found that a single inhalation session with 25% nitrous oxide gas was nearly as effective as 50% nitrous oxide at rapidly relieving symptoms of treatment-resistant depression, with fewer adverse side effects.
A small pilot study provides an early glimpse of how some veterans struggling with PTSD may benefit from one simple, inexpensive treatment involving nitrous oxide, commonly known as laughing gas.
Choice and control are important factors for ensuring a positive childbirth experience, yet until recently, little was known about the impact of alternative administrations of fentanyl – one of the pain relief drugs used during labour– on both mother and baby.
California’s nitrous oxide (NO₂) air pollution has been reduced by a combination of the state’s COVID-19 lockdown and naturally occurring effects, according to an atmospheric scientist at The University of Alabama in Huntsville (UAH)